ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Verisk Enters Egypt Health Insurance Market Through AXA Deal

CAIRO, Egypt, Aug. 28, 2023 (GLOBE NEWSWIRE) -- AXA Life & Health Reinsurance Solutions has selected Verisk’s Health Risk Rating Tool and Ratings Engine to help its insurance partners in Egypt automate health insurance underwriting based on the declared pre-existing medical conditions of their customers. This deal marks the first time Verisk, a global data analytics and technology provider for insurers, provides a product or service to Egypt’s insurance market.

Verisk’s Health Risk Rating Tool, which will be marketed as AXA’s Intelligent Medical Acceptance Tool (IMPACT), enables insurers to grow by helping them make more informed underwriting decisions at point of sale. The solution analyses an applicant’s responses to a dynamic question set, assesses the applicant’s pre-existing medical conditions, and generates risk scores that insurers can use to better understand the cost of maintaining a condition and any potential complications.

Verisk’s Health Risk Ratings Engine is an additional module of the solution that streamlines the process by allowing insurers to configure their own rules based on the risk scores and generate real-time automated underwriting decisions.

“The new Ratings Engine feature of the Health Risk Rating Tool has vastly improved IMPACT’s accessibility and efficiency in providing bespoke health insurance products to a wider demographic of customers,” said Laurent Pochat-Cottilloux, CEO of AXA Life & Health Reinsurance Solutions. “Customers with pre-existing medical conditions should now have a much better experience finding cover that suits them.”

This deal builds on an existing business relationship between Verisk and AXA Life & Health Reinsurance, with AXA using Verisk’s Health Risk Rating Tool in China, Vietnam and the Philippines.

“Our entry into Egypt’s health market is not only a significant achievement in expanding our global presence in EMEA but it is also a positive step forward in our ongoing relationship with AXA,” said Rachel Edwards, Managing Director of Verisk Life, Health & Travel. “The addition of the Ratings Engine to our product suite has expanded the value Verisk can add to our customers’ underwriting process and has greatly assisted AXA’s launch in Egypt.”

The Health Risk Rating Tool is available as a standalone portal or as an integrated API. For more information, e-mail riskrating@verisk.com.

Verisk's Life, Health & Travel business has worked with insurers to automate the assessment of pre-existing conditions with the Risk Rating Tool since 2000. The integration of Verisk's software into the workflows of insurers, brokers, distributors, banks and price comparison websites has established the Risk Rating Tool as a leading solution in the marketplace.

About Verisk 

Verisk (Nasdaq: VRSK) is a leading strategic data analytics and technology partner to the global insurance industry. It empowers clients to strengthen operating efficiency, improve underwriting and claims outcomes, combat fraud and make informed decisions about global risks, including climate change, extreme events, ESG and political issues. Through advanced data analytics, software, scientific research and deep industry knowledge, Verisk helps build global resilience for individuals, communities and businesses. With teams across more than 20 countries, Verisk consistently earns certification by Great Place to Work and fosters an inclusive culture where all team members feel they belong. For more, visit Verisk.com and the Verisk Newsroom


Media Contact
Mary Keller
Verisk
(339) 832-7048
mary.keller@verisk.com

Primary Logo

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.